Apelin
An endogenous peptide ligand for the APJ receptor with cardiovascular and metabolic research relevance.
Also appears in: Other
This compound has a genuine development or study trail, but it is not an approved routine drug.
Primary lane: Hormone. Also surfaces under Other for browsing and discovery.
No major aliases are tracked for this profile yet.
No FDA label signal · 64 trials · 2923 PubMed results
What apelin is
Apelin is an endogenous peptide ligand of the APJ receptor and has been studied in cardiovascular, fluid-balance, and metabolic contexts.
Why it matters
It helps strengthen the library’s scientific credibility by covering important physiology peptides that are real and relevant even when they are not gray-market hype names.
Regulatory context
Apelin is not FDA approved as a standard peptide therapy in the United States.
Practical reading note
Apelin is the kind of peptide that makes the library smarter, not just bigger.